CAMBRIDGE, Mass., Nov. 25, 2024 /PRNewswire/ -- Akebia Therapeutics^®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a Fireside Discussion at the 36^th Annual Piper Sandler Healthcare Conference on Tuesday, December 3^rd at 10:30 AM EST.

A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 6 months following the conference.

The Piper Sandler Healthcare Conference will take place December 3-5, 2024 in New York.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-36th-annual-piper-sandler-healthcare-conference-302315009.html

SOURCE Akebia Therapeutics, Inc.